Skip to main content
logo
Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
0.2877
-0.0292 (-9.21%)
At close: Sep 18, 2026, 4:00 PM EDT
0.2849
-0.0028 (-0.97%)
After-hours: Sep 18, 2026, 7:47 PM EDT

Immutep Revenue

In the fiscal year ending June 30, 2026, Immutep had annual revenue of 14.60M AUD with 24,344.44% growth. Immutep had revenue of 10.50M in the half year ending June 30, 2026, with 34,682.21% growth.

Revenue (ttm)
14.60M AUD
Revenue Growth
+24,344.44%
P/S Ratio
2.89
Revenue / Employee
470,824 AUD
Employees
31
Market Cap
39.81M USD

Revenue Chart

Chart
* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202614.60M14.54M24,344.44%
Jun 30, 202559.71K-59.38K-49.86%
Jun 30, 2024119.09K-72.63K-37.88%
Jun 30, 2023191.72K-62.67K-24.63%
Jun 30, 2022254.39K-58.45K-18.68%
Jun 30, 2021312.84K-7.45M-95.97%
Jun 30, 20207.77M6.47M499.78%
Jun 30, 20191.29M-2.34M-64.42%
Jun 30, 20183.64M2.84M354.63%
Jun 30, 2017800.46K625.41K357.27%
Jun 30, 2016175.05K--
Jun 30, 2015---
Jun 30, 2014---
Jun 30, 2013---
Jun 30, 2012---
Jun 30, 2011---
Jun 30, 2010---
Jun 30, 2009---
Jun 30, 2008---
Jun 30, 2007---
Jun 30, 2006---
Jun 30, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Karyopharm Therapeutics146.62M
Actinium Pharmaceuticals35.09M
Celularity26.55M
Veru Inc.16.89M
Metagenomi Therapeutics13.56M
Seres Therapeutics1.88M
CervoMed331.30K
aTyr Pharma190.00K
Revenue Rankings

IMMP News

More News